Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Catherine Obrien

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
12
2021
155
2.870
Why?
Students, Pharmacy
5
2019
125
1.400
Why?
Patient-Centered Care
2
2019
140
1.070
Why?
Education, Pharmacy
5
2019
151
0.940
Why?
Professional-Patient Relations
3
2019
47
0.860
Why?
Schools, Pharmacy
3
2019
56
0.780
Why?
Alprostadil
2
2011
10
0.690
Why?
Educational Measurement
5
2019
195
0.690
Why?
Constipation
2
2011
37
0.680
Why?
Pharmacists
2
2019
141
0.590
Why?
Curriculum
7
2019
394
0.560
Why?
Radius
1
2018
27
0.550
Why?
Neutrophils
2
2015
147
0.490
Why?
Respiratory System
1
2015
28
0.480
Why?
Tracheostomy
1
2015
76
0.450
Why?
Respiratory Tract Infections
1
2015
82
0.450
Why?
Dietary Supplements
2
2012
464
0.440
Why?
Health Knowledge, Attitudes, Practice
2
2016
509
0.430
Why?
Gastric Acid
1
2013
9
0.420
Why?
Enterocolitis, Pseudomembranous
1
2013
24
0.410
Why?
Dietetics
1
2012
11
0.400
Why?
Nutrition Therapy
1
2012
20
0.390
Why?
Lung
2
2013
499
0.390
Why?
Lymphocytes
1
2013
148
0.390
Why?
Tomography, X-Ray Computed
1
2018
1162
0.380
Why?
Enteral Nutrition
1
2012
155
0.370
Why?
Motivational Interviewing
2
2019
32
0.310
Why?
Cesium
1
2008
8
0.300
Why?
Pharmaceutical Services
2
2019
50
0.290
Why?
Chlorides
1
2008
43
0.290
Why?
Humans
23
2021
52469
0.290
Why?
Problem-Based Learning
1
2008
50
0.280
Why?
Pseudomonas Infections
2
2019
54
0.270
Why?
Pseudomonas aeruginosa
2
2019
77
0.270
Why?
Education, Medical, Undergraduate
1
2008
85
0.270
Why?
Pilot Projects
4
2018
719
0.270
Why?
Electrocardiography
1
2008
279
0.250
Why?
Students, Medical
1
2008
158
0.250
Why?
Child
7
2018
7188
0.230
Why?
Depression
2
2021
604
0.230
Why?
Adolescent
7
2015
6708
0.220
Why?
Female
13
2019
28192
0.210
Why?
Male
12
2019
26794
0.200
Why?
Infant
4
2015
3691
0.200
Why?
Anti-Bacterial Agents
2
2019
802
0.180
Why?
Vitamin D Deficiency
1
2012
46
0.180
Why?
Vitamin D
1
2012
90
0.180
Why?
College Admission Test
2
2018
13
0.180
Why?
School Admission Criteria
2
2018
35
0.170
Why?
Chloride Channels
2
2011
26
0.170
Why?
Forced Expiratory Volume
3
2019
52
0.170
Why?
Off-Label Use
1
2019
24
0.160
Why?
Pneumonia, Bacterial
1
2019
30
0.160
Why?
Airway Management
1
2019
17
0.150
Why?
Mass Screening
1
2012
358
0.150
Why?
Self Efficacy
1
2019
135
0.140
Why?
Patient Compliance
1
2019
229
0.140
Why?
Communication
1
2019
257
0.140
Why?
Absorptiometry, Photon
1
2018
161
0.130
Why?
Retrospective Studies
4
2018
6643
0.130
Why?
Case-Control Studies
2
2018
1198
0.130
Why?
Adult
8
2021
14151
0.130
Why?
Health Behavior
1
2019
257
0.130
Why?
Education, Pharmacy, Graduate
1
2016
20
0.120
Why?
Young Adult
4
2018
4326
0.120
Why?
Drug Repositioning
1
2015
13
0.120
Why?
Bone Density
1
2018
398
0.120
Why?
Fenofibrate
1
2015
17
0.120
Why?
Quinolines
1
2015
43
0.110
Why?
Methicillin-Resistant Staphylococcus aureus
1
2015
80
0.110
Why?
Acetates
1
2015
52
0.110
Why?
Epithelial Cells
1
2015
214
0.110
Why?
Megacolon, Toxic
1
2013
3
0.110
Why?
Antacids
1
2013
11
0.100
Why?
Leukocyte Count
1
2013
73
0.100
Why?
Appetite Stimulants
1
2012
5
0.100
Why?
Colon
1
2013
105
0.100
Why?
Fatal Outcome
1
2013
194
0.100
Why?
Enzymes
1
2012
29
0.100
Why?
Proton Pump Inhibitors
1
2013
86
0.100
Why?
Staphylococcal Infections
1
2015
280
0.100
Why?
Cross-Sectional Studies
1
2018
1680
0.100
Why?
Gastrostomy
1
2012
58
0.100
Why?
Zinc
1
2012
56
0.100
Why?
Health Care Surveys
1
2012
177
0.090
Why?
Dietary Fats
1
2012
129
0.090
Why?
Bone Diseases
1
2012
94
0.090
Why?
Biopsy
1
2013
602
0.090
Why?
Body Composition
1
2013
339
0.090
Why?
Inflammation
1
2015
643
0.090
Why?
Asthma
1
2015
316
0.080
Why?
Diet, High-Fat
1
2012
237
0.080
Why?
Internet
1
2012
261
0.080
Why?
Body Mass Index
1
2013
691
0.080
Why?
Treatment Outcome
2
2011
5471
0.080
Why?
Mental Disorders
1
2015
428
0.080
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2010
39
0.080
Why?
Intestinal Obstruction
1
2010
38
0.080
Why?
Secondary Prevention
1
2010
85
0.080
Why?
Coronary Artery Disease
1
2012
320
0.070
Why?
Biphenyl Compounds
1
2008
31
0.070
Why?
Adaptation, Psychological
2
2021
229
0.070
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
44
0.070
Why?
Tetrazoles
1
2008
41
0.070
Why?
Infant, Newborn
1
2015
2875
0.070
Why?
Self-Assessment
1
2008
43
0.070
Why?
Benzimidazoles
1
2008
50
0.070
Why?
Peer Group
1
2008
58
0.070
Why?
Longitudinal Studies
2
2021
746
0.070
Why?
Program Development
1
2008
165
0.070
Why?
Child, Preschool
1
2015
4034
0.070
Why?
Program Evaluation
1
2008
351
0.060
Why?
Carcinoma, Hepatocellular
1
2008
201
0.060
Why?
Blood Pressure
1
2008
536
0.060
Why?
Clinical Competence
1
2008
399
0.060
Why?
Risk Factors
1
2013
3945
0.060
Why?
Liver Neoplasms
1
2008
333
0.060
Why?
Hypertension
1
2008
568
0.050
Why?
Logistic Models
2
2016
932
0.050
Why?
Ergocalciferols
1
2012
1
0.050
Why?
25-Hydroxyvitamin D 2
1
2012
2
0.050
Why?
Malabsorption Syndromes
1
2012
8
0.050
Why?
Calcifediol
1
2012
8
0.050
Why?
Cholecalciferol
1
2012
22
0.050
Why?
Seasons
1
2012
92
0.050
Why?
Evidence-Based Practice
1
2012
111
0.040
Why?
Spirituality
1
2021
31
0.040
Why?
Administration, Inhalation
1
2019
115
0.040
Why?
Respiratory Function Tests
1
2019
90
0.040
Why?
Dose-Response Relationship, Drug
2
2015
1372
0.040
Why?
Age Factors
1
2012
1131
0.040
Why?
Middle Aged
3
2019
13084
0.040
Why?
Pharmacy
1
2018
54
0.030
Why?
Social Support
1
2019
268
0.030
Why?
Universities
1
2018
175
0.030
Why?
Anxiety
1
2019
301
0.030
Why?
Disease Progression
1
2019
872
0.030
Why?
Chemokine CXCL5
1
2015
7
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
51
0.030
Why?
Bronchi
1
2015
42
0.030
Why?
Granulocyte Colony-Stimulating Factor
1
2015
64
0.030
Why?
Chemokines
1
2015
78
0.030
Why?
Interleukin-8
1
2015
86
0.030
Why?
Sulfides
1
2015
29
0.030
Why?
Cyclopropanes
1
2015
27
0.030
Why?
Anti-Asthmatic Agents
1
2015
33
0.030
Why?
Tumor Necrosis Factor-alpha
1
2015
395
0.030
Why?
Cells, Cultured
1
2015
1586
0.020
Why?
Gene Expression Profiling
1
2015
1108
0.020
Why?
Blood Pressure Monitoring, Ambulatory
1
2008
34
0.020
Why?
United States
1
2019
5225
0.020
Why?
Obrien's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description